Dishman Sept qtr PAT seen up 21% at Rs 10cr: Dolat Capital
Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Dishman September quarter net sales are expected to go up by 15.1% at Rs 245 crore, year-on-year, (YoY) basis.